CovalX

Description

CovalX characterizes therapeutic proteins and biologics using mass spectrometry services, including epitope mapping, HDX-MS, XL-MS, LC-MS, MALDI-MS, sequence verification, modification analysis, and interaction assays for biotherapeutic characterization.

CovalX is located in the Zurich ecosystem.

Related

• MaxWell BiosystemsMaxWell Biosystems provides high-density microelectrode array (HD-MEA) platforms, combining multiwell and single-well devices with software…
• Molecular PartnersMolecular Partners develops DARPin therapeutics, including Radio-DARPins and logic-gated Switch-DARPins, to target DLL3, FAP x CD40, and…
• IBA LifesciencesIBA Lifesciences develops research tools based on Strep-tag® technology for protein and cell isolation, providing purification and analysis…
• Dynamic BiosensorsDynamic Biosensors develops switchSENSE® and single-cell Interaction Cytometry (scIC) technologies that characterize molecular interactions…
• AcytronixAcytronix provides PMED, a portable microstructured electrochemical device that rapidly isolates extracellular vesicles from biofluids…
• UNISERSUNISERS develops contamination analysis for semiconductor manufacturing, using vacuum-based plasma coating to make wafer impurities visible…
• IngenzaIngenza provides protein CRDMO services and custom biotech solutions for biologics, small molecules and sustainable biotech, offering…
• OrexoOrexo develops powder-based drug delivery technologies and therapeutic formulations, including AmorphOX®, used to improve bioavailability…
• BiodiatechBiodiatech offers metabolomic diagnosis and therapy monitoring through targeted and untargeted assays, HRUS imaging in small animals, and…